Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates

US7241595B2 · kind B2 · utility

Assignee

• sanofi-aventis Pharma Deutschland GmbH · DE

Inventors

• Cenek Kolar · Marburg, DE
• Jorg Czech · Marburg, DE
• Klaus Bosslet · Marburg, DE
• Gerhard Seemann · Lahntal, DE
• Hans-Harald Sedlacek · Marburg, DE

Key dates

• Filing date: Apr 24, 2002
• Grant date: Jul 10, 2007
• Expiry date: Nov 3, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers.